These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37148007)

  • 1. An immunohistochemical evaluation of tumor-associated macrophages (M1 and M2) in carcinoma prostate - An institutional study.
    Hadimani SM; Das S; Harish KG
    J Cancer Res Ther; 2023 Apr; 19(Supplement):S300-S305. PubMed ID: 37148007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-dimensional computed tomography-guided monotherapeutic pararectal brachytherapy of prostate cancer with seminal vesicle invasion.
    Koutrouvelis P; Lailas N; Hendricks F; Gil-Montero G; Sehn J; Katz S
    Radiother Oncol; 2001 Jul; 60(1):31-5. PubMed ID: 11410301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathologic assessment of tumor-associated macrophages and their histologic localization in invasive breast carcinoma.
    Mwafy SE; El-Guindy DM
    J Egypt Natl Canc Inst; 2020 Jan; 32(1):6. PubMed ID: 32372332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radical prostatectomy and postoperative irradiation in patients with pathological stage C (T3) carcinoma of the prostate.
    Petrovich Z; Lieskovsky G; Langholz B; Formenti S; Baert L; Streeter O; Skinner DG
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):139-47. PubMed ID: 9422570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of CD44 Expression in Prostatic Adenocarcinoma: An Institutional Study.
    Damarasingu PV; Das S; Mh S; Bodapati S
    Cureus; 2023 Jun; 15(6):e40510. PubMed ID: 37461792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infiltrates of M2-Like Tumour-Associated Macrophages Are Adverse Prognostic Factor in Patients with Human Papillomavirus-Negative but Not in Human Papillomavirus-Positive Oropharyngeal Squamous Cell Carcinoma.
    Snietura M; Brewczynski A; Kopec A; Rutkowski T
    Pathobiology; 2020; 87(2):75-86. PubMed ID: 32036360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-associated macrophages and PD-L1 in prostate cancer: a possible key to unlocking immunotherapy efficacy.
    Wang J; Wu W; Yuan T; Wang L; Zang L; Liu Q; Wang L; Huo X; Huo B; Tang Y; Wang H; Zhao Z
    Aging (Albany NY); 2024 Jan; 16(1):445-465. PubMed ID: 38189834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of lymphatic spreading in prostatic cancer by prostate-specific antigen and Gleason's score.
    Wu TT; Chen KK; Huang JK; Lee YH; Chen MT; Chang LS
    Eur Urol; 1994; 26(3):202-6. PubMed ID: 7528661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative assessment of CD68+ AND CD163+ macrophages in the primary focus and metastatic lesions of regional lymph nodes in non-luminal her2-positive invasive breast carcinoma.
    Aikian AZ; Shynkevych VI; Kaidashev IP
    Wiad Lek; 2019 Oct; 72(10):1861-1865. PubMed ID: 31932263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-associated macrophage, angiogenesis and lymphangiogenesis markers predict prognosis of non-small cell lung cancer patients.
    Hwang I; Kim JW; Ylaya K; Chung EJ; Kitano H; Perry C; Hanaoka J; Fukuoka J; Chung JY; Hewitt SM
    J Transl Med; 2020 Nov; 18(1):443. PubMed ID: 33228719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic significance of p34cdc2 and cyclin D1 protein expression in prostate adenocarcinoma.
    Kallakury BV; Sheehan CE; Ambros RA; Fisher HA; Kaufman RP; Ross JS
    Cancer; 1997 Aug; 80(4):753-63. PubMed ID: 9264360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage type 2 differentiation in a patient with laryngeal squamous cell carcinoma and metastatic prostate adenocarcinoma to the cervical lymph nodes.
    Topf MC; Tuluc M; Harshyne LA; Luginbuhl A
    J Immunother Cancer; 2017 Jul; 5(1):60. PubMed ID: 28716144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relation of serum prostate-specific antigen and the Gleason grade in patients with prostatic carcinoma].
    Zivković S; Velicković L; Kostov M; Stojanović N
    Vojnosanit Pregl; 2003; 60(4):449-54. PubMed ID: 12958804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of pelvic lymph node metastasis by the ratio of cathepsin B to stefin A in patients with prostate carcinoma.
    Sinha AA; Quast BJ; Wilson MJ; Fernandes ET; Reddy PK; Ewing SL; Gleason DF
    Cancer; 2002 Jun; 94(12):3141-9. PubMed ID: 12115346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial cell proliferation in prostatic carcinoma and prostatic hyperplasia: correlation with Gleason's score, microvessel density, and epithelial cell proliferation.
    Vartanian RK; Weidner N
    Lab Invest; 1995 Dec; 73(6):844-50. PubMed ID: 8558846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune cell analyses of the tumor microenvironment in prostate cancer highlight infiltrating regulatory T cells and macrophages as adverse prognostic factors.
    Andersen LB; Nørgaard M; Rasmussen M; Fredsøe J; Borre M; Ulhøi BP; Sørensen KD
    J Pathol; 2021 Oct; 255(2):155-165. PubMed ID: 34255349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic and predictive value of CD163 expression and the CD163/CD68 expression ratio for response to adjuvant chemotherapy in patients with surgically resected lung squamous cell carcinoma.
    Yanagawa N; Shikanai S; Sugai M; Koike Y; Asai Y; Tanji T; Sugimoto R; Osakabe M; Uesugi N; Saito H; Maemondo M; Sugai T
    Thorac Cancer; 2023 Jul; 14(20):1911-1920. PubMed ID: 37208929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The correlation between tumor-associated macrophage infiltration and progression in cervical carcinoma.
    Guo F; Kong W; Zhao G; Cheng Z; Ai L; Lv J; Feng Y; Ma X
    Biosci Rep; 2021 May; 41(5):. PubMed ID: 33928349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the current incidence of nodal metastasis from prostate cancer.
    Bundrick WS; Culkin DJ; Mata JA; Zitman RI; Venable DD
    J Surg Oncol; 1993 Apr; 52(4):269-71. PubMed ID: 7682265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.